Amalgamation
As filed · Indegene Limited has informed the Exchange about Amalgamation/Merger
What happened
FactIndegene Limited has announced the amalgamation of its step down subsidiaries, Indegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc., to form Indegene Healthcare Canada Inc., effective January 01, 2026. Both subsidiaries were 100% held by Indegene, Inc., a wholly owned subsidiary of Indegene Limited. Further details are available in the company's disclosure on its website.
Why it matters
CapitSignal interpretationA merger fixes a share-exchange ratio, which permanently sets how much of the combined company existing holders own.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
RevisedOur Q4 adjusted EBITDA came in at ₹1,889 million, growing 23.2% year-over-year.
The full year adjusted EBITDA totalled ₹6,793 million, up 20.8% year-on-year.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Swap ratio and its valuation basis
- Regulatory and NCLT approvals required
- Appointed date
- Reflecting this strength, the Board has recommended a final dividend of ₹2.25 per share - a 12.5% increase ove (management committed by FY26)
- With a strong pipeline and an industry-leading revenue per employee of $75k, we will build on this momentum in (management committed by FY27)
Evidence
- Indegene Limited has informed the Exchange about Amalgamation/Merger(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q4 FY26
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- MERGER base 74; +2 corroborating keywords; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%